Form 8-K
8-K — Turning Point Brands, Inc.
Accession: 0001437749-26-015354
Filed: 2026-05-07
Period: 2026-05-07
CIK: 0001290677
SIC: 2100 (TOBACCO PRODUCTS)
Item: Results of Operations and Financial Condition
Item: Financial Statements and Exhibits
Documents
8-K — tpb20260309_8k.htm (Primary)
EX-99.1 — EXHIBIT 99.1 (ex_930472.htm)
GRAPHIC (image01.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: tpb20260309_8k.htm · Sequence: 1
tpb20260309_8k.htm
false
0001290677
0001290677
2026-05-07
2026-05-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 7, 2026
TURNING POINT BRANDS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-37763
20-0709285
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
5201 Interchange Way, Louisville, KY
40229
(Address of principal executive offices)
(Zip Code)
(502) 778-4421
N/A
(Former name, former address and former fiscal year, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
TPB
New York Stock Exchange
Check the appropriate box below if the Form 8–K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On May 7, 2026, Turning Point Brands, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter and three months ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information will not be incorporated by reference into any registration statement filed by the Company under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.
Item 7.01.
Regulation FD Disclosure.
On May 7, 2026, the Company posted an investor presentation with supplemental information for the quarter ended March 31, 2026 to the investor relations section of its website at the following link https://www.turningpointbrands.com/investor-relations/events-and-presentations.
The information furnished under Item 7.01 of this Current Report on Form 8-K, including the referenced investor presentation, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits
99.1
Press Release dated May 7, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TURNING POINT BRANDS, INC.
Dated: May 7, 2026
By:
/s/ Brittani N. Cushman
Brittani N. Cushman
Senior Vice President, General Counsel and Secretary
EX-99.1 — EXHIBIT 99.1
EX-99.1
Filename: ex_930472.htm · Sequence: 2
ex_930472.htm
Exhibit 99.1
Turning Point Brands Announces First Quarter 2026 Results
●
Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million, accounting for 42% of total company net sales, up from 21% in Q1 2025.
●
Raising FY 2026 Modern Oral Sales guidance; Introducing FY 2026 EBITDA guidance
LOUISVILLE, KY – May 7, 2026 – Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the first quarter ended March 31, 2026.
Q1 2026 Financial Highlights
(All results reflect comparisons to prior-year period)
●
Total Consolidated Net Sales increased 16.8% to $124.3 million
o
Stoker's segment Net Sales increased 48.1%
o
Zig-Zag segment Net Sales decreased 22.4%
●
Gross Profit increased 14.6% to $68.3 million
●
Net Income decreased 19.0% to $11.7 million
●
Adjusted EBITDA decreased 6.5% to $25.9 million (see Schedule A for a reconciliation to net income)
●
Diluted EPS of $0.60 and Adjusted Diluted EPS of $0.76 compared to $0.79 and $0.91 respectively, in the same period one year ago (see Schedule B for a reconciliation to Diluted EPS)
“We delivered a strong first quarter, driven by continued momentum in Modern Oral and disciplined execution across the portfolio,” said Graham Purdy, President and CEO. “We believe we are in the early stages of a generational shift in nicotine consumption, with significant opportunity ahead as the category continues to evolve. We are investing behind our brands, commercial capabilities, and consumer reach to position us to capture meaningful share in white pouch, including through initiatives such as our recently announced TKO partnership featuring UFC. At the same time, our legacy brands continue to generate strong cash flow, providing the foundation to fund our strategic priorities. We remain confident in our ability to scale our modern oral business and drive long-term value for shareholders.”
Stoker’s Products Segment (70% of total net sales in the quarter)
For the first quarter, Stoker’s segment net sales increased 48.1% from the prior year to $87.6 million, driven by triple-digit growth in Modern Oral net sales.
For the first quarter, Stoker’s segment gross profit increased 39.1% from the prior year to $47.3 million. Gross profit as a percentage of net sales decreased to 54.0% for the three months ended March 31, 2026, from 57.5% of net sales for the three months ended March 31, 2025, primarily driven by margin contribution from modern oral products.
Zig-Zag Products Segment (30% of total net sales in the quarter)
For the first quarter, Zig-Zag segment net sales decreased 22.4% from the prior year to $36.7 million. The decrease in net sales was driven primarily by lower U.S. papers and wraps shipments.
For the first quarter, Zig-Zag segment gross profit decreased 18.1% from the prior year to $20.9 million. Gross profit as a percentage of net sales increased to 57.1% for the three months ended March 31, 2026, from 54.1% for the three months ended March 31, 2025, driven primarily by product mix.
Performance Measures in the First Quarter
Investment in the first quarter focused on sales and marketing efforts to support distribution and brand building. In the first quarter consolidated selling, general and administrative (“SG&A”) expenses increased 53.2% from the prior year to $55.8 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs.
As of March 31, 2026 , ending cash was $192.4 million and net debt was $101.4 million. The Company ended the quarter with total liquidity of $265.0 million, comprised of $192.4 million in cash and $72.6 million of asset backed revolving credit facility capacity.
2
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
2026 Outlook
●
Full year Modern Oral Gross Sales of $280-$300 million (from $220- $240 million)
●
Full year Modern Oral Net Sales of $210-$225 million (from $180- $190 million)
●
Full Year Adjusted EBITDA of $70-$90 million, inclusive of investment in Modern Oral sales, marketing, and trade promotions
Earnings Conference Call
As previously disclosed, a conference call with the investment community to review TPB’s financial results has been scheduled for 8:30 a.m. Eastern on Thursday, May 7, 2026. Investment community participants should dial in 10 minutes ahead of time using the toll-free number (800) 715-9871 (international participants should call (646) 307-1963) and follow the audio prompts after typing in the event ID: 4128483. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call.
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Adjusted Operating Income (Loss). A reconciliation of these non-GAAP financial measures accompanies this release. Also note that a reconciliation of forward-looking non-GAAP measures, including EBITDA, to the most directly comparable GAAP measures is not provided because comparable GAAP measures for such measures are not reasonably accessible or reliable due to the inherent difficulty in forecasting and quantifying measures that would be necessary for such reconciliation.
About Turning Point Brands, Inc.
Turning Point Brands, Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker’s®, FRE®, and ALP®. TPB’s products are available in more than 220,000 retail outlets in North America and on sites such as www.zigzag.com, www.frepouch.com, and www.alppouch.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.
3
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including our outlook for 2026 with respect to Modern Oral Gross and Net Sales and Adjusted EBITDA . Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the “SEC”) and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, those included in the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995.
This press release contains TPB’s preliminary determinations and current expectations, and such information is inherently uncertain. The preliminary estimates provided herein have been prepared by, and are the responsibility of, management and are subject to completion of TPB's customary quarter-end closing and review procedures and third-party review. As a result, TPB's reported information in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 may differ from this information, and any such differences may be material. In addition, the information furnished above does not include all of the information regarding TPB's financial condition and results of operations for the quarter ending March 31, 2026 that may be important to readers. As a result, readers are cautioned not to place undue reliance on the information furnished in this press release and should view this information in the context of TPB's full first quarter 2026 results when such results are disclosed by TPB in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
Investor Contacts
Turning Point Brands, Inc.
ir@tpbi.com
Financial Statements Follow on Subsequent Pages
4
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Turning Point Brands, Inc.
Consolidated Statements of Income
(dollars in thousands except share data)
(unaudited)
Three Months Ended March 31,
2026
2025
Net sales
$
124,278
$
106,436
Cost of sales
55,983
46,826
Gross profit
68,295
59,610
Selling, general, and administrative expenses
55,811
36,421
Operating income
12,484
23,189
Other expense, net
63
-
Interest expense, net
4,423
4,414
Investment gain
(151
)
(141
)
Income from equity method investment
(2,983
)
(150
)
Loss on extinguishment of debt
-
1,235
Income from continuing operations before income taxes
11,132
17,831
Income tax (benefit) expense
(2,810
)
2,040
Consolidated net income
13,942
15,791
Net income attributable to non-controlling interest
2,275
1,396
Net income attributable to Turning Point Brands, Inc.
$
11,667
$
14,395
Basic income per common share:
Net income attributable to Turning Point Brands, Inc.
$
0.61
$
0.81
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.
$
0.60
$
0.79
Weighted average common shares outstanding:
Basic
19,214,389
17,795,243
Diluted
19,474,877
18,249,306
5
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Turning Point Brands, Inc.
Consolidated Balance Sheets
(dollars in thousands except share data)
(unaudited)
March 31,
December 31,
ASSETS
2026
2025
Current assets:
Cash
$
192,439
$
222,760
Accounts receivable, net of allowances of $228 in 2026 and $206 in 2025
27,473
25,726
Inventories, net
129,580
107,989
Other current assets
68,712
60,675
Total current assets
418,204
417,150
Property, plant, and equipment, net
40,584
36,247
Right of use assets
15,409
14,480
Deferred financing costs, net
1,019
1,180
Goodwill
135,974
136,097
Other intangible assets, net
63,731
64,042
Master Settlement Agreement (MSA) escrow deposits
29,786
29,887
Other assets
67,390
64,667
Total assets
$
772,097
$
763,750
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
35,889
$
20,420
Accrued liabilities
35,394
54,587
Total current liabilities
71,283
75,007
Deferred income tax liability
8,363
8,289
Notes payable and long-term debt
293,885
293,625
Other long-term liabilities
2,034
4,138
Lease liabilities
11,043
10,708
Total liabilities
386,608
391,767
Stockholders’ equity:
Preferred stock, $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-
-
-
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 20,824,677 issued shares and 19,367,534 outstanding shares at March 31, 2026, and 20,589,527 issued shares and 19,132,384 outstanding shares at December 31, 2025
218
216
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-
-
-
Additional paid-in capital
205,542
203,627
Cost of repurchased common stock (1,457,143 shares at March 31, 2026 and 1,457,143 shares at December 31, 2025)
(47,637
)
(47,637
)
Accumulated other comprehensive loss
(2,090
)
(1,563
)
Accumulated earnings
209,730
199,661
Non-controlling interest
19,726
17,679
Total stockholders’ equity
385,489
371,983
Total liabilities and stockholders’ equity
$
772,097
$
763,750
6
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Turning Point Brands, Inc.
Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
Three Months Ended March 31,
2026
2025
Cash flows from operating activities:
Consolidated net income
$
13,942
$
15,791
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on extinguishment of debt
-
1,235
Loss on sale of property, plant, and equipment
-
40
Income from equity method investment
(2,983
)
(150
)
Gain on investments
(15
)
-
Depreciation and other amortization expense
1,753
1,309
Amortization of other intangible assets
306
307
Amortization of deferred financing costs
421
448
Deferred income tax expense
96
1,716
Stock compensation expense
2,938
1,664
Noncash lease income
(807
)
(380
)
Changes in operating assets and liabilities:
Accounts receivable
(1,941
)
(5,539
)
Inventories
(21,700
)
(8,310
)
Other current assets
(8,062
)
(5,399
)
Other assets
(108
)
(1,268
)
Accounts payable
15,637
15,433
Accrued liabilities and other
(21,736
)
512
Net cash (used in) provided by operating activities
$
(22,259
)
$
17,409
Cash flows from investing activities:
Capital expenditures
$
(5,139
)
$
(2,185
)
Payment for equity investments
-
(2,783
)
Purchases of investments
(2,283
)
(714
)
Proceeds from sale of investments
2,351
500
MSA escrow deposits, net
5
(48
)
Net cash used in investing activities
$
(5,066
)
$
(5,230
)
Cash flows from financing activities:
Redemption of 2026 Notes
$
-
$
(250,000
)
Proceeds from 2032 Notes
-
300,000
Payment of dividends
(1,671
)
(1,385
)
Payments of financing costs
-
(6,582
)
Exercise of options
323
973
Redemption of options
-
(33
)
Redemption of restricted stock units
(330
)
(1,828
)
Redemption of performance based restricted stock units
(1,014
)
(2,625
)
Net cash (used in) provided by financing activities
$
(2,692
)
$
38,520
Net (decrease) increase in cash
$
(30,017
)
$
50,699
Effect of foreign currency translation on cash
$
(304
)
$
(48
)
Cash, beginning of period:
Unrestricted
$
222,760
$
48,941
Restricted
1,914
1,961
Total cash at beginning of period
$
224,674
$
50,902
Cash, end of period:
Unrestricted
$
192,439
$
99,640
Restricted
1,914
1,913
Total cash at end of period
$
194,353
$
101,553
7
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Non-GAAP Financial Measures
To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income (Loss). We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income (Loss) are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Adjusted Operating Income (Loss) are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.
We define “EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization. We define “Adjusted EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Net Income” as net income excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Diluted EPS” as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Operating Income (Loss)” as operating income (loss) excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance.
Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted Net Income, Adjusted EBITDA, Adjusted Diluted EPS, and Adjusted Operating Income (Loss) exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.
In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures. Note that a reconciliation of forward-looking non-GAAP measures, including EBITDA, to the most directly comparable GAAP measures is not provided because comparable GAAP measures for such measures are not reasonably accessible or reliable due to the inherent difficulty in forecasting and quantifying measures that would be necessary for such reconciliation.
8
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Schedule A
Turning Point Brands, Inc.
Reconciliation of GAAP Net Income to Adjusted EBITDA
(dollars in thousands)
(unaudited)
Three Months Ended
March 31,
2026
2025
Net income attributable to Turning Point Brands, Inc.
$
11,667
$
14,395
Add:
Interest expense, net
4,569
4,401
Loss on extinguishment of debt
-
1,235
Income tax (benefit) expense
(2,492
)
2,040
Depreciation expense
794
828
Amortization expense
1,285
822
EBITDA
$
15,823
$
23,721
Components of Adjusted EBITDA
Corporate restructuring (a)
97
-
ERP/CRM (b)
-
211
Stock based compensation (c)
2,938
1,664
Transactional expenses and strategic initiatives (d)
145
176
Non-recurring legal (e)
153
-
FDA PMTA (f)
290
1,591
Mark-to-market gain on Canadian inter-company note (g)
(116
)
315
Tariff adjustment (h)
5,903
-
Manufacturing start-up costs (i)
594
-
Honorarium (j)
63
-
Adjusted EBITDA
$
25,890
$
27,678
(a)
Represents costs associated with corporate restructuring, including severance and early retirement.
(b)
Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
(c)
Represents non-cash stock options, restricted stock, PSRUs, etc.
(d)
Represents the fees incurred for transaction expenses.
(e)
Represents legal expenses incurred in connection with litigation related to an insurance claim.
(f)
Represents costs associated with applications related to FDA premarket tobacco production application ("PMTA").The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a one-time resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the pending two are complete.
(g)
Represents a mark-to-market loss attributable to foreign exchange fluctuation.
(h)
Represents adjustment to current period costs of goods sold to exclude tariffs subject to refund.
(i)
Represents non-recurring expenses incurred during the start-up of manufacturing lines.
(j)
Represents an honorarium gift included in other expense, net.
9
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
Schedule B
Turning Point Brands
Reconciliation of GAAP Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS
(dollars in thousands except share data)
(unaudited)
Three Months Ended
Three Months Ended
March 31, 2026
March 31, 2025
Income from continuing operations before income taxes
Income tax expense (m)
Net loss attributable to non-controlling interest
Adjusted Net Income
Adjusted Diluted EPS
Income from continuing operations before income taxes
Income tax expense (m)
Net loss attributable to non-controlling interest
Net Income
Diluted EPS
GAAP Net Income and Diluted EPS
$
11,132
$
(2,810
)
$
2,275
$
11,667
$
0.60
$
17,831
$
2,040
$
1,396
$
14,395
$
0.79
Loss on extinguishment of debt (a)
-
-
-
-
-
1,235
141
-
1,094
0.06
Corporate restructuring (b)
97
(24
)
-
121
0.01
-
-
-
-
-
ERP/CRM (c)
-
-
-
-
-
211
24
-
187
0.01
Stock based compensation (d)
2,938
(742
)
-
3,680
0.19
1,664
190
-
1,474
0.08
Transactional expenses and strategic initiatives(e)
145
(37
)
-
182
0.01
176
20
-
156
0.01
Non-recurring legal (f)
153
(39
)
-
192
0.01
-
-
-
-
-
FDA PMTA (g)
290
(73
)
-
363
0.02
1,591
182
-
1,409
0.08
Mark-to-market loss on Canadian inter-company note (h)
(116
)
29
-
(145
)
(0.01
)
315
36
-
279
0.02
Tariff adjustment (i)
5,903
(1,490
)
-
7,393
0.38
-
-
-
-
-
Manufacturing start-up costs (j)
594
(150
)
-
744
0.04
-
-
-
-
-
Honorarium (k)
63
(16
)
-
79
0.00
-
-
-
-
-
Tax benefit (l)
-
9,475
-
(9,475
)
(0.49
)
-
2,329
-
(2,329
)
(0.13
)
Adjusted Net Income and Adjusted Diluted EPS
$
21,199
$
4,124
$
2,275
$
14,800
$
0.76
$
23,023
$
4,963
$
1,396
$
16,664
$
0.91
(a)
Represents loss on extinguishment of debt as a result of the redemptions of the 2026 Notes.
(b)
Represents costs associated with corporate restructuring, including severance and early retirement.
(c)
Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
(d)
Represents non-cash stock options, restricted stock, PSRUs, etc.
(e)
Represents the fees incurred for transaction expenses.
(f)
Represents legal expenses incurred in connection with litigation related to an insurance claim.
(g)
Represents costs associated with applications related to FDA premarket tobacco production application ("PMTA").The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a one-time resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the pending two are complete.
(h)
Represents a mark-to-market loss attributable to foreign exchange fluctuation.
(i)
Represents adjustment to current period costs of goods sold to exclude tariffs subject to refund.
(j)
Represents non-recurring expenses incurred during the start-up of manufacturing lines.
(k)
Represents an honorarium gift included in other expense, net.
(l)
Represents adjustment from quarterly tax rate to quarterly projected tax rate of 24% in 2026 and 21% in 2025.
(m)
Income tax expense calculated using the effective tax rate for the quarter of -25.2% in 2026 and 11.4% in 2025.
10
Turning Point Brands, Inc. | www.turningpointbrands.com | ir@tpbi.com | 502.774.9238
GRAPHIC
GRAPHIC
Filename: image01.jpg · Sequence: 7
Binary file (10962 bytes)
Download image01.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 9
v3.26.1
Document And Entity Information
May 07, 2026
Document Information [Line Items]
Entity, Registrant Name
TURNING POINT BRANDS, INC.
Document, Type
8-K
Document, Period End Date
May 07, 2026
Entity, Incorporation, State or Country Code
DE
Entity, File Number
001-37763
Entity, Tax Identification Number
20-0709285
Entity, Address, Address Line One
5201 Interchange Way
Entity, Address, City or Town
Louisville
Entity, Address, State or Province
KY
Entity, Address, Postal Zip Code
40229
City Area Code
502
Local Phone Number
778-4421
Title of 12(b) Security
Common Stock
Trading Symbol
TPB
Security Exchange Name
NYSE
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Entity, Emerging Growth Company
false
Amendment Flag
false
Entity, Central Index Key
0001290677
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details
Name:
dei_DocumentInformationLineItems
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration